Introduction
T cell leukemia/lymphoma
VIRUS
The retrovirus human T‐lymphotropic virus type 1 (HTLV‐1) is the etiologic agent for adult T cell leukemia/lymphoma
In this open‐label, single‐arm, Phase 2 trial, we evaluated the efficacy and safety of short‐term treatment with orally administered 